Document Detail


Issues and controversies in venous thromboembolism.
MedLine Citation:
PMID:  9988957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper gives specific recommendations on a number of issues in venous thromboembolism: how to evaluate idiopathic deep vein thrombosis (DVT); how to treat calf vein thrombosis and upper-extremity DVT; how to use low-molecular-weight heparin, vena cava filters, catheter-directed thrombolytic therapy, and compression stockings; how long to continue anticoagulation therapy; and how to manage recurrent DVT.
Authors:
T L Carman; B B Fernandez
Related Documents :
18328307 - Venous thromboembolism in patients hospitalized with nephrotic syndrome.
7060947 - Fibrinolytic guidelines in diabetes.
15472587 - Perforator vein incompetence in chronic venous disease: a multivariate regression analy...
3537067 - Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embo...
16519137 - Reversal of delayed-onset paraplegia with thrombectomy of an interposed graft for the i...
8431047 - Homograft aortic root replacement for destructive prosthetic endocarditis.
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  66     ISSN:  0891-1150     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-03-02     Completed Date:  1999-03-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  113-23     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Cleveland Clinic, Florida, Fort Lauderdale, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anticoagulants / therapeutic use
Arm / blood supply
Bandages
Blood Coagulation Disorders / complications
Female
Fibrinolytic Agents / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Male
Neoplasms / complications
Pregnancy
Recurrence
Thrombolytic Therapy
Thrombophlebitis / drug therapy
Vena Cava Filters
Venous Thrombosis* / diagnosis,  etiology,  therapy
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents; 0/Heparin, Low-Molecular-Weight
Comments/Corrections
Comment In:
Cleve Clin J Med. 1999 Nov-Dec;66(10):584   [PMID:  10598360 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aggressive blood pressure lowering is safe, but benefit is still hard to prove.
Next Document:  Development of a computerized database for evaluation of nurse practitioner student clinical experie...